OpenAI shifts partners
OpenAI signalled a strategic shift away from Microsoft and toward tighter ties with Amazon internally, while simultaneously deepening industry deals. (axios.com) That posture shows up commercially: Novo Nordisk has entered a partnership with OpenAI to apply its tools across drug discovery, manufacturing and commercial operations. (reuters.com)
OpenAI is redrawing its alliances, loosening Microsoft’s grip while pushing deeper into Amazon-linked infrastructure and big corporate deals. (axios.com) Axios reported on April 13 that OpenAI executives told staff Microsoft had limited the company’s reach, even as OpenAI tightened ties with Amazon and attacked rival Anthropic in an internal memo. (axios.com) That shift follows formal changes already made to the Microsoft relationship. In January 2025, Microsoft said OpenAI’s cloud arrangement was no longer exclusive and had moved to a right-of-first-refusal model for new capacity instead. (blogs.microsoft.com) OpenAI then widened its infrastructure map through Stargate, the data-center buildout it announced in January 2025 with SoftBank, Oracle and MGX as equity backers and Microsoft listed as an initial technology partner. (openai.com) By September 2025, OpenAI, Oracle and SoftBank said Stargate had expanded to five new United States sites as part of a plan for $500 billion of artificial intelligence infrastructure and 10 gigawatts of capacity. (openai.com) The commercial side is moving in parallel. Novo Nordisk said Tuesday, April 14, that it had entered a strategic partnership with OpenAI to use its tools across drug discovery, manufacturing and commercial operations. (biospace.com) Reuters reported the deal is aimed at speeding drug development as Novo Nordisk tries to defend its position in the fast-growing obesity-drug market led by Wegovy and Ozempic. (money.usnews.com) Novo Nordisk said the rollout will include workforce upskilling, strict data governance and human oversight, a sign that the company is treating the agreement as an operating change, not just a research pilot. (biospace.com) OpenAI has been building for this market. In its enterprise report published in late 2025, the company said it was seeing deeper adoption across business customers, based on usage data and a survey of 9,000 workers across almost 100 enterprises. (openai.com) Microsoft and OpenAI also said in a joint statement on February 27, 2026, that they were continuing to work together, underscoring that the change is not a clean break so much as a broader partner mix. (openai.com) The result is a more spread-out OpenAI: Microsoft still matters, but the company is now pairing new cloud and infrastructure partners with industry-specific contracts that put its models inside the day-to-day work of companies like Novo Nordisk. (axios.com)
